Jennifer D. Wu

8.6k total citations · 3 hit papers
77 papers, 6.2k citations indexed

About

Jennifer D. Wu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jennifer D. Wu has authored 77 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 36 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Jennifer D. Wu's work include Immune Cell Function and Interaction (40 papers), CAR-T cell therapy research (19 papers) and T-cell and B-cell Immunology (19 papers). Jennifer D. Wu is often cited by papers focused on Immune Cell Function and Interaction (40 papers), CAR-T cell therapy research (19 papers) and T-cell and B-cell Immunology (19 papers). Jennifer D. Wu collaborates with scholars based in United States, China and Canada. Jennifer D. Wu's co-authors include Thomas A. Spies, Veronika Groh, Cassian Yee, Stephen R. Plymate, Derek A. Wainwright, Kathy Haugk, Payal Dhar, David Cosman, Sizhe Liu and Alexander Steinle and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jennifer D. Wu

76 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

2002 1.3k citations Veronika Groh, Jennifer D. Wu et al. Nature profile →
NK cell-based cancer immunotherapy: from basic biology to clinical development

2021 485 citations Sizhe Liu, Derek A. Wainwright et al. Journal of Hematology & Oncology profile →
The CXCL8-CXCR1/2 pathways in cancer

2016 478 citations Anping Li, Yijun Tian et al. profile →

Peers

Countries citing papers authored by Jennifer D. Wu

Since Specialization

Citations

This map shows the geographic impact of Jennifer D. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer D. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer D. Wu more than expected).

Fields of papers citing papers by Jennifer D. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer D. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer D. Wu. The network helps show where Jennifer D. Wu may publish in the future.

Co-authorship network of co-authors of Jennifer D. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer D. Wu. A scholar is included among the top collaborators of Jennifer D. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer D. Wu. Jennifer D. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype 2024 ·Molecular Cancer Research ·Joseph E. Ippolito, (unknown), (unknown), (unknown), Jennifer K. Sehn, Cody Weimholt, (unknown), (unknown), Nikolaos A. Trikalinos, Deyali Chatterjee, Eric H. Kim, Anand S. Mehta, Peggi M. Angel, Dean A. Troyer, Robin J. Leach, Eva Corey, Jennifer D. Wu, Richard R. Drake	2
2	Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI 2024 ·Cancer Research Communications ·(unknown), (unknown), Lyndsay E.A. Young, (unknown), Jennifer R. Bethard, Dean A. Troyer, (unknown), Jennifer D. Wu, Joseph E. Ippolito, Lauren E. Ball, Jonathan Gelfond, Teresa L. Johnson‐Pais, Anand S. Mehta, Robin J. Leach, Peggi M. Angel, Richard R. Drake	4
3	Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges 2024 ·BioDrugs ·Jennifer D. Wu	4
4	The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes 2024 ·Biomedicines ·Anthony V. Serritella, (unknown), Payal Dhar, Sizhe Liu, (unknown), Shengxian Jia, Qi Cao, Jennifer D. Wu	2
5	Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations 2023 ·Clinical Immunology ·Chuang‐Wei Wang, (unknown), Chun‐Bing Chen, Wei‐Chen Lin, Jennifer D. Wu, Chun‐Wei Lu, (unknown), (unknown), Rosaline Chung‐Yee Hui, (unknown), Tsu‐Man Chiu, Ya‐Ching Chang, (unknown), Yang Lin, Wan-Ting Tsai, Wen‐Hung Chung, Wen‐Hung Chung	6
6	Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology 2021 ·Cancer Prevention Research ·Kristin Wallace, (unknown), (unknown), Jessica E. Thaxton, David Lewin, Nana Nikolaishvili‐Feinberg, Stephanie M. Cohen, (unknown), Elizabeth G. Hill, Jennifer D. Wu, John A. Baron, Alexander V. Alekseyenko	4
7	Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes 2021 ·Nature Communications ·Adam B. Weiner, Thiago Vidotto, Yang Liu, Adrianna A. Mendes, Daniela C. Salles, Farzana A. Faisal, Sanjana Murali, Matthew McFarlane, Eddie L. Imada, (unknown), Ziwen Li, Elai Davicioni, Luigi Marchionni, Arul M. Chinnaiyan, Stephen J. Freedland, Daniel E. Spratt, Jennifer D. Wu, Tamara L. Lotan, Edward M. Schaeffer	65
8	Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation 2021 ·Communications Biology ·Payal Dhar, (unknown), Zhe Ji, Lei Huang, Si Qin, Derek A. Wainwright, Jerid W. Robinson, (unknown), Jing Zhou, Sean Mackay, Jennifer D. Wu	12
9	Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy 2019 ·Journal for ImmunoTherapy of Cancer ·Jinyu Zhang, (unknown), Bin Zhang, Derek A. Wainwright, Payal Dhar, Jennifer D. Wu	25
10	Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging 2019 ·JCI Insight ·Denise P. Muñoz, Steven M. Yannone, Anneleen Daemen, Yu Sun, Funda Vakar‐Lopez, Misako Kawahara, Adam Freund, Françis Rodier, Jennifer D. Wu, Pierre-Yves Desprez, David H. Raulet, Peter S. Nelson, Laura van ‘t Veer, Judith Campisi, Jean-Philippe Coppé	118
11	NKG2D and its ligands in cancer 2018 ·Current Opinion in Immunology ·Payal Dhar, Jennifer D. Wu	180
12	Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue 2017 ·Journal of Hematology & Oncology ·Gang Liu, Jinyu Zhang, Lewis J. Frey, Gang Xiao, Kongming Wu, Qian Liu, Michelle M. Lilly, Jennifer D. Wu	26
13	The expression profile and clinic significance of the SIX family in non-small cell lung cancer 2016 ·Journal of Hematology & Oncology ·Qian Liu, Anping Li, Yijun Tian, Yu Liu, Tengfei Li, (unknown), Jennifer D. Wu, Xinwei Han, Kongming Wu	59
14	Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors 2015 ·Clinical Cancer Research ·Shengjun Lu, Jinyu Zhang, Dai Liu, Guangfu Li, Kevin F. Staveley-O’Carroll, Zihai Li, Jennifer D. Wu	39
15	Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancer 2015 ·OncoImmunology ·Jennifer D. Wu	11
16	Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis 2013 ·Journal of Clinical Investigation ·Gang Liu, Shengjun Lu, Xuanjun Wang, Stephanie T. Page, Celestia S. Higano, Stephen R. Plymate, Norman M. Greenberg, Shaoli Sun, Zihai Li, Jennifer D. Wu	97
17	Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases 2010 ·The Journal of Immunology ·Gang Liu, (unknown), Xuanjun Wang, (unknown), Jennifer D. Wu	113
18	Oxidative DNA Damage in the Prostate May Predispose Men to a Higher Risk of Prostate Cancer 2009 ·Translational Oncology ·Jennifer D. Wu, Daniel W. Lin, Stephanie T. Page, (unknown), Lawrence D. True, Stephen R. Plymate	14
19	Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein 2003 ·The Journal of Immunology ·Jennifer D. Wu, N. Jan Chalupny, Thomas Manley, Stanley R. Riddell, David Cosman, Thomas A. Spies	117
20	Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation breakdown → 2002 ·Nature ·Veronika Groh, Jennifer D. Wu, Cassian Yee, Thomas A. Spies	1268

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact